Ask AI
ProCE Banner Series

Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction

In this highly interactive Masterclass, healthcare professionals will engage in case-based learning to address major gaps in ASCVD prevention, including lipoprotein(a) testing, personalized lipid-lowering strategies, and barriers to guideline-directed care. Faculty will provide practical guidance to support improved patient outcomes.

This event is not part of ACC.26 and is not sponsored or endorsed by the American College of Cardiology. This event does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Who Should Attend

This educational activity is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with ASCVD.

All Events

Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction

Upcoming Events

March

28

2026

5:30 PM - 7:30 PM Central Time (CT)

In-person

New Orleans Marriott Warehouse Arts District, 859 Convention Center Blvd., New Orleans, Louisiana 70130

6:00 PM - 7:30 PM Central Time (CT)

Virtual

Topics

Dyslipidemia

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Dyslipidemia.

Target Audience
This educational activity is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with ASCVD.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Recognize Lp(a) as an alternative biomarker of ASCVD risk and of residual risk when taking LDL-C into account

  • Plan individualized, guideline-recommended lipid-lowering treatment strategies using nonstatin or combination therapies to improve patient outcomes, as measured by Lp(a)

  • Implement guideline-directed ASCVD care that addresses gaps in patient-centered approaches and avoids clinical inertia.

Accreditation

This activity is not certified for CME/CE credit.

 

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191